Annual CFO
-$110.90 M
-$4.60 M-4.33%
December 31, 2023
Summary
- As of February 26, 2025, MYGN annual cash flow from operations is -$110.90 million, with the most recent change of -$4.60 million (-4.33%) on December 31, 2023.
- During the last 3 years, MYGN annual CFO has fallen by -$37.20 million (-50.47%).
- MYGN annual CFO is now -158.31% below its all-time high of $190.20 million, reached on June 30, 2014.
Performance
MYGN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
$700.00 K
-$1.90 M-73.08%
September 30, 2024
Summary
- As of February 26, 2025, MYGN quarterly cash flow from operations is $700.00 thousand, with the most recent change of -$1.90 million (-73.08%) on September 30, 2024.
- Over the past year, MYGN quarterly CFO has increased by +$55.40 million (+101.28%).
- MYGN quarterly CFO is now -99.37% below its all-time high of $111.84 million, reached on June 30, 2008.
Performance
MYGN Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$70.00 M
+$22.80 M+24.57%
September 30, 2024
Summary
- As of February 26, 2025, MYGN TTM cash flow from operations is -$70.00 million, with the most recent change of +$22.80 million (+24.57%) on September 30, 2024.
- Over the past year, MYGN TTM CFO has increased by +$40.90 million (+36.88%).
- MYGN TTM CFO is now -129.35% below its all-time high of $238.46 million, reached on December 31, 2013.
Performance
MYGN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
MYGN Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.3% | +101.3% | +36.9% |
| 3 y3 years | -50.5% | +101.3% | +36.9% |
| 5 y5 years | -232.5% | +101.3% | +36.9% |
MYGN Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -696.2% | at low | -73.1% | +101.3% | -476.3% | +51.7% |
| 5 y | 5-year | -232.5% | at low | -99.0% | +101.2% | -212.5% | +51.7% |
| alltime | all time | -158.3% | at low | -99.4% | +101.2% | -129.3% | +51.7% |
Myriad Genetics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $700.00 K(-73.1%) | -$70.00 M(-24.6%) |
| Jun 2024 | - | $2.60 M(-114.0%) | -$92.80 M(-3.6%) |
| Mar 2024 | - | -$18.60 M(-66.0%) | -$96.30 M(-13.2%) |
| Dec 2023 | -$110.90 M(+4.3%) | -$54.70 M(+147.5%) | -$110.90 M(+74.6%) |
| Sep 2023 | - | -$22.10 M(+2355.6%) | -$63.50 M(+43.7%) |
| Jun 2023 | - | -$900.00 K(-97.3%) | -$44.20 M(-52.5%) |
| Mar 2023 | - | -$33.20 M(+354.8%) | -$93.00 M(-12.5%) |
| Dec 2022 | -$106.30 M(-671.5%) | -$7.30 M(+160.7%) | -$106.30 M(-2.0%) |
| Sep 2022 | - | -$2.80 M(-94.4%) | -$108.50 M(-25.2%) |
| Jun 2022 | - | -$49.70 M(+6.9%) | -$145.00 M(+45.4%) |
| Mar 2022 | - | -$46.50 M(+389.5%) | -$99.70 M(-636.0%) |
| Dec 2021 | $18.60 M(-125.2%) | -$9.50 M(-75.8%) | $18.60 M(-33.8%) |
| Sep 2021 | - | -$39.30 M(+793.2%) | $28.10 M(+246.9%) |
| Jun 2021 | - | -$4.40 M(-106.1%) | $8.10 M(-80.9%) |
| Mar 2021 | - | $71.80 M(-221.1%) | $42.50 M(-395.1%) |
| Dec 2020 | -$73.70 M(-221.4%) | - | - |
| Sep 2020 | - | -$59.30 M(-297.7%) | -$14.40 M(-123.7%) |
| Jun 2020 | $60.70 M(-27.5%) | $30.00 M(+78.6%) | $60.70 M(-2.4%) |
| Mar 2020 | - | $16.80 M(-984.2%) | $62.20 M(+19.6%) |
| Dec 2019 | - | -$1.90 M(-112.0%) | $52.00 M(-43.3%) |
| Sep 2019 | - | $15.80 M(-49.8%) | $91.70 M(+9.6%) |
| Jun 2019 | $83.70 M(-27.8%) | $31.50 M(+377.3%) | $83.70 M(-16.4%) |
| Mar 2019 | - | $6.60 M(-82.5%) | $100.10 M(-4.7%) |
| Dec 2018 | - | $37.80 M(+384.6%) | $105.00 M(+4.8%) |
| Sep 2018 | - | $7.80 M(-83.7%) | $100.20 M(-13.5%) |
| Jun 2018 | $115.90 M(+9.1%) | $47.90 M(+316.5%) | $115.90 M(+10.8%) |
| Mar 2018 | - | $11.50 M(-65.2%) | $104.60 M(-22.1%) |
| Dec 2017 | - | $33.00 M(+40.4%) | $134.20 M(+1.2%) |
| Sep 2017 | - | $23.50 M(-35.8%) | $132.60 M(+24.9%) |
| Jun 2017 | $106.20 M(-36.1%) | $36.60 M(-10.9%) | $106.20 M(-1.8%) |
| Mar 2017 | - | $41.10 M(+30.9%) | $108.10 M(-4.3%) |
| Dec 2016 | - | $31.40 M(-1182.8%) | $112.90 M(-15.5%) |
| Sep 2016 | - | -$2.90 M(-107.5%) | $133.60 M(-19.7%) |
| Jun 2016 | $166.30 M(+18.4%) | $38.50 M(-16.1%) | $166.30 M(-7.0%) |
| Mar 2016 | - | $45.90 M(-11.9%) | $178.80 M(+9.8%) |
| Dec 2015 | - | $52.10 M(+74.8%) | $162.80 M(-0.3%) |
| Sep 2015 | - | $29.80 M(-41.6%) | $163.30 M(+16.2%) |
| Jun 2015 | $140.50 M(-26.1%) | $51.00 M(+70.6%) | $140.50 M(+7.7%) |
| Mar 2015 | - | $29.90 M(-43.2%) | $130.42 M(+16.7%) |
| Dec 2014 | - | $52.60 M(+651.4%) | $111.77 M(+4.7%) |
| Sep 2014 | - | $7.00 M(-82.9%) | $106.72 M(-43.9%) |
| Jun 2014 | $190.20 M(+9.4%) | $40.92 M(+263.8%) | $190.20 M(-10.4%) |
| Mar 2014 | - | $11.25 M(-76.3%) | $212.31 M(-11.0%) |
| Dec 2013 | - | $47.55 M(-47.4%) | $238.46 M(+11.9%) |
| Sep 2013 | - | $90.48 M(+43.5%) | $213.03 M(+22.5%) |
| Jun 2013 | $173.90 M(+22.6%) | $63.03 M(+68.6%) | $173.90 M(+14.0%) |
| Mar 2013 | - | $37.40 M(+69.1%) | $152.57 M(-2.1%) |
| Dec 2012 | - | $22.11 M(-56.9%) | $155.92 M(-3.4%) |
| Sep 2012 | - | $51.36 M(+23.1%) | $161.34 M(+13.8%) |
| Jun 2012 | $141.80 M(+8.4%) | $41.70 M(+2.3%) | $141.80 M(+3.9%) |
| Mar 2012 | - | $40.75 M(+48.0%) | $136.47 M(+10.3%) |
| Dec 2011 | - | $27.53 M(-13.5%) | $123.76 M(-7.2%) |
| Sep 2011 | - | $31.82 M(-12.5%) | $133.36 M(+1.9%) |
| Jun 2011 | $130.83 M(-15.6%) | $36.37 M(+29.7%) | $130.83 M(-7.2%) |
| Mar 2011 | - | $28.04 M(-24.5%) | $140.98 M(-9.4%) |
| Dec 2010 | - | $37.13 M(+26.7%) | $155.60 M(-3.5%) |
| Sep 2010 | - | $29.30 M(-37.0%) | $161.20 M(+3.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2010 | $155.09 M(+84.5%) | $46.52 M(+9.1%) | $155.09 M(+5.1%) |
| Mar 2010 | - | $42.66 M(-0.2%) | $147.49 M(+30.9%) |
| Dec 2009 | - | $42.73 M(+84.3%) | $112.71 M(+1.0%) |
| Sep 2009 | - | $23.18 M(-40.5%) | $111.62 M(+32.8%) |
| Jun 2009 | $84.04 M(-19.0%) | $38.93 M(+394.7%) | $84.04 M(-46.5%) |
| Mar 2009 | - | $7.87 M(-81.1%) | $156.95 M(+2.2%) |
| Dec 2008 | - | $41.64 M(-1046.6%) | $153.53 M(+37.0%) |
| Sep 2008 | - | -$4.40 M(-103.9%) | $112.03 M(+8.0%) |
| Jun 2008 | $103.74 M(-501.3%) | $111.84 M(+2416.7%) | $103.74 M(-1421.5%) |
| Mar 2008 | - | $4.44 M(+2862.7%) | -$7.85 M(-54.4%) |
| Dec 2007 | - | $150.00 K(-101.2%) | -$17.21 M(-29.0%) |
| Sep 2007 | - | -$12.70 M(-5099.2%) | -$24.25 M(-6.2%) |
| Jun 2007 | -$25.85 M(-7.8%) | $254.00 K(-105.2%) | -$25.85 M(-12.1%) |
| Mar 2007 | - | -$4.92 M(-28.5%) | -$29.39 M(-6.3%) |
| Dec 2006 | - | -$6.88 M(-51.9%) | -$31.36 M(-0.1%) |
| Sep 2006 | - | -$14.30 M(+334.9%) | -$31.38 M(+12.0%) |
| Jun 2006 | -$28.03 M(+20.3%) | -$3.29 M(-52.3%) | -$28.03 M(+20.6%) |
| Mar 2006 | - | -$6.89 M(-0.2%) | -$23.24 M(-7.2%) |
| Dec 2005 | - | -$6.90 M(-37.0%) | -$25.04 M(+11.4%) |
| Sep 2005 | - | -$10.95 M(-829.5%) | -$22.48 M(-3.5%) |
| Jun 2005 | -$23.30 M(-24.5%) | $1.50 M(-117.3%) | -$23.30 M(-25.5%) |
| Mar 2005 | - | -$8.69 M(+100.0%) | -$31.29 M(+17.6%) |
| Dec 2004 | - | -$4.34 M(-63.1%) | -$26.60 M(-8.2%) |
| Sep 2004 | - | -$11.77 M(+81.6%) | -$28.98 M(-6.2%) |
| Jun 2004 | -$30.88 M(-33.6%) | -$6.49 M(+62.3%) | -$30.88 M(+19.6%) |
| Mar 2004 | - | -$4.00 M(-40.6%) | -$25.83 M(-34.7%) |
| Dec 2003 | - | -$6.72 M(-50.8%) | -$39.57 M(-6.1%) |
| Sep 2003 | - | -$13.68 M(+854.3%) | -$42.16 M(-9.4%) |
| Jun 2003 | -$46.54 M(+185.3%) | -$1.43 M(-91.9%) | -$46.54 M(+14.1%) |
| Mar 2003 | - | -$17.74 M(+90.5%) | -$40.79 M(+34.6%) |
| Dec 2002 | - | -$9.31 M(-48.4%) | -$30.31 M(+23.5%) |
| Sep 2002 | - | -$18.06 M(-518.4%) | -$24.55 M(+50.5%) |
| Jun 2002 | -$16.31 M(+332.1%) | $4.32 M(-159.5%) | -$16.31 M(-2.9%) |
| Mar 2002 | - | -$7.26 M(+104.3%) | -$16.79 M(+92.7%) |
| Dec 2001 | - | -$3.55 M(-63.8%) | -$8.71 M(+4.9%) |
| Sep 2001 | - | -$9.82 M(-356.0%) | -$8.31 M(+120.1%) |
| Jun 2001 | -$3.78 M(-122.0%) | $3.84 M(+366.0%) | -$3.78 M(+52.8%) |
| Mar 2001 | - | $823.30 K(-126.2%) | -$2.47 M(-10.9%) |
| Dec 2000 | - | -$3.15 M(-40.5%) | -$2.77 M(-177.5%) |
| Sep 2000 | - | -$5.29 M(-202.9%) | $3.57 M(-79.2%) |
| Jun 2000 | $17.16 M(-221.7%) | $5.14 M(+885.0%) | $17.16 M(+108.8%) |
| Mar 2000 | - | $522.00 K(-83.7%) | $8.22 M(+64.4%) |
| Dec 1999 | - | $3.20 M(-61.4%) | $5.00 M(-484.6%) |
| Sep 1999 | - | $8.30 M(-318.4%) | -$1.30 M(-90.8%) |
| Jun 1999 | -$14.10 M(+101.4%) | -$3.80 M(+40.7%) | -$14.10 M(+15.6%) |
| Mar 1999 | - | -$2.70 M(-12.9%) | -$12.20 M(0.0%) |
| Dec 1998 | - | -$3.10 M(-31.1%) | -$12.20 M(+11.9%) |
| Sep 1998 | - | -$4.50 M(+136.8%) | -$10.90 M(+55.7%) |
| Jun 1998 | -$7.00 M(+6.1%) | -$1.90 M(-29.6%) | -$7.00 M(+150.0%) |
| Mar 1998 | - | -$2.70 M(+50.0%) | -$2.80 M(-28.2%) |
| Dec 1997 | - | -$1.80 M(+200.0%) | -$3.90 M(-30.4%) |
| Sep 1997 | - | -$600.00 K(-126.1%) | -$5.60 M(-15.2%) |
| Jun 1997 | -$6.60 M(-571.4%) | $2.30 M(-160.5%) | -$6.60 M(-25.8%) |
| Mar 1997 | - | -$3.80 M(+8.6%) | -$8.90 M(+74.5%) |
| Dec 1996 | - | -$3.50 M(+118.8%) | -$5.10 M(+218.8%) |
| Sep 1996 | - | -$1.60 M | -$1.60 M |
| Jun 1996 | $1.40 M | - | - |
FAQ
- What is Myriad Genetics annual cash flow from operations?
- What is the all time high annual CFO for Myriad Genetics?
- What is Myriad Genetics annual CFO year-on-year change?
- What is Myriad Genetics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Myriad Genetics?
- What is Myriad Genetics quarterly CFO year-on-year change?
- What is Myriad Genetics TTM cash flow from operations?
- What is the all time high TTM CFO for Myriad Genetics?
- What is Myriad Genetics TTM CFO year-on-year change?
What is Myriad Genetics annual cash flow from operations?
The current annual CFO of MYGN is -$110.90 M
What is the all time high annual CFO for Myriad Genetics?
Myriad Genetics all-time high annual cash flow from operations is $190.20 M
What is Myriad Genetics annual CFO year-on-year change?
Over the past year, MYGN annual cash flow from operations has changed by -$4.60 M (-4.33%)
What is Myriad Genetics quarterly cash flow from operations?
The current quarterly CFO of MYGN is $700.00 K
What is the all time high quarterly CFO for Myriad Genetics?
Myriad Genetics all-time high quarterly cash flow from operations is $111.84 M
What is Myriad Genetics quarterly CFO year-on-year change?
Over the past year, MYGN quarterly cash flow from operations has changed by +$55.40 M (+101.28%)
What is Myriad Genetics TTM cash flow from operations?
The current TTM CFO of MYGN is -$70.00 M
What is the all time high TTM CFO for Myriad Genetics?
Myriad Genetics all-time high TTM cash flow from operations is $238.46 M
What is Myriad Genetics TTM CFO year-on-year change?
Over the past year, MYGN TTM cash flow from operations has changed by +$40.90 M (+36.88%)